IHE Stock Overview
iShares Trust - iShares U.S. Pharmaceuticals ETF is an exchange traded fund launched by BlackRock, Inc.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
iShares Trust - iShares U.S. Pharmaceuticals ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$63.19 |
52 Week High | US$69.56 |
52 Week Low | US$55.36 |
Beta | 0 |
1 Month Change | -5.34% |
3 Month Change | 0.67% |
1 Year Change | 4.92% |
3 Year Change | 4.04% |
5 Year Change | 28.94% |
Change since IPO | 277.92% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
IHE | US Capital Markets | US Market | |
---|---|---|---|
7D | -3.2% | -2.6% | -3.7% |
1Y | 4.9% | 22.7% | 20.5% |
Return vs Industry: IHE underperformed the US Capital Markets industry which returned 22.2% over the past year.
Return vs Market: IHE underperformed the US Market which returned 20.2% over the past year.
Price Volatility
IHE volatility | |
---|---|
IHE Average Weekly Movement | 1.8% |
Capital Markets Industry Average Movement | 3.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IHE has not had significant price volatility in the past 3 months.
Volatility Over Time: IHE's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | n/a | n/a | www.ishares.com/us/products/239519/ishares-us-pharmaceuticals-etf |
iShares Trust - iShares U.S. Pharmaceuticals ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. It invests in public equity markets of the United States.
iShares Trust - iShares U.S. Pharmaceuticals ETF Fundamentals Summary
IHE fundamental statistics | |
---|---|
Market cap | US$639.53m |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs IHE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IHE income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did IHE perform over the long term?
See historical performance and comparison